Eyepoint Pharmaceuticals, Inc. (EYPT)

Trade EYPT now with
2/2/2021 12:11:28 AM EyePoint Pharma Prices Public Offering Of 9.1 Mln Shares At $11/Shr
12/18/2020 7:22:41 AM EyePoint Announces Royalty Monetization Agreement With SWK Holdings
12/3/2020 7:12:17 AM EyePoint Pharma Announces Positive Results From Good Laboratory Practice Preclinical Toxicology Study Of EYP-1901
10/7/2020 7:10:34 AM EyePoint Pharma Sees Q3 Net Product Revenues Of Between $5.5 - $5.9 Mln
8/24/2020 7:12:27 AM EyePoint Pharma Secures New Purchase And Marketing Agreement With Vantage Outsourcing For DEXYCU
5/18/2020 7:10:47 AM EyePoint Presents Data Showcasing DEXYCU At ASCRS 2020 Virtual Annual Meeting
3/5/2020 7:06:08 AM EyePoint Q4 Net Loss $10.4 Mln Or $0.10/Shr
3/2/2020 7:10:58 AM EyePoint Reports Positive Topline 36-month Follow-up Data For Second Phase 3 Study Of YUTIQ
2/21/2020 9:11:29 AM EyePoint Pricies Public Offering Of 15 Mln Shares At $1.45 Per Share
2/18/2020 7:15:33 AM EyePoint, Vision Center Network Of America Sign Purchase Agreement For DEXYCU
1/27/2020 7:10:50 AM EyePoint, Ocumension Enter Exclusive License Agreement For DEXYCU 9%
7/15/2019 7:04:49 AM EyePoint Pharmaceuticals Appoints Wendy DiCicco To Board
6/13/2019 7:08:08 AM EyePoint Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
3/28/2019 9:29:36 AM EyePoint Pharma Announces Pricing Of Underwritten Public Offering Of 10.53 Mln Shares At $1.90/shr